Walmart Shares Fall After Oppenheimer Downgrade; Pharmacy Revenue Risk Highlighted
Walmart shares fell in pre-market trading after Oppenheimer cut its rating to Perform from Outperform and withdrew a $140 price target, pointing to potential top-line pressure in the company’s U.S. pharmacy business linked to the Inflation Reduction Act. The downgrade, issued just over two weeks before Walmart reports Q2 results on August 20, comes…